ROYCE & ASSOCIATES LP

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 906304 New York, NY

Position in SPRY

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$433,812

-$1,978,332 QoQ

Shares Held

54,024

-73.9% QoQ

Ownership

0.054%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

ROYCE & ASSOCIATES LP holds $280,717,366 across 29 Biotechnology names. SPRY ranks #26 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CPRX	Catalyst Pharmaceuticals, Inc.	2,089,906	$51,746,072
2	TECH	BIO-TECHNE Corp	759,712	$39,702,549
3	INVA	Innoviva, Inc.	1,061,448	$24,731,738
4	BBIO	BridgeBio Pharma, Inc.	232,923	$17,296,861
5	AXSM	Axsome Therapeutics, Inc.	94,017	$15,890,753
6	ORIC	Oric Pharmaceuticals, Inc.	1,207,223	$15,295,515
7	CRMD	CorMedix Inc.	1,887,532	$12,816,342
8	CNTA	Centessa Pharmaceuticals plc	278,064	$11,044,702

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$433,812	54,024	-73.9%	Shares	Sole	2026-05-12
2025-12-31	$2,412,144	207,051	-19.2%	Shares	Sole	2026-02-09
2025-06-30	$4,471,894	256,269	-60.1%	Shares	Sole	2025-08-11
2025-03-31	$8,085,996	642,766	-30.9%	Shares	Sole	2025-05-06
2024-12-31	$9,807,417	929,613	+34.4%	Shares	Sole	2025-02-10
2024-09-30	$10,026,097	691,455	+7.1%	Shares	Sole	2024-11-06
2024-06-30	$5,494,907	645,700	+15.6%	Shares	Sole	2024-08-13
2024-03-31	$5,709,914	558,700	+17.9%	Shares	Sole	2024-05-13
2023-12-31	$2,595,876	473,700	+2.2%	Shares	Sole	2024-02-12
2023-09-30	$1,752,786	463,700	0.0%	Shares	Sole	2023-11-09
2023-06-30	$3,106,790	463,700	+52.6%	Shares	Sole	2023-08-07
2023-03-31	$1,978,389	303,900	—	Shares	Sole	2023-05-23
No filing history on record for this holder in this stock.